At the AUA congress in Chicago, Prof. Leonard Marks and the UCLA group presented a method for focal HIFU, employing multiparametric magnetic resonance imaging, fusion biopsy, margin generation, and targeted treatment. UCLA physicians are convinced that high-intensity focused ultrasound (HIFU) can be used to ablate prostate cancer focally, non-invasively, and with minimal side effects.